BTAIVSGNPX• 3 Months (Normalized)
BTAI vs GNPX (BioXcel Therapeutics Inc. vs Genprex Inc.)
Showing Closing Date Range from Jun, 17 to Sep, 15, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
BTAI Performance $0.04
-96.24%
BioXcel Therapeutics Inc.
Normalized Baseline0.00%
GNPX Performance $3.31
-68.85%
Genprex Inc.
Normalized Baseline0.00%
Alpha Spread Margin GNPX LEADS
-27.39%
GNPX outperforming by 27.39%
BTAIGNPX
Spread Trajectory3 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
BTAI GNPX
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(62 dates)
| Date | BTAI Price | BTAI Gain (%) | GNPX Price | GNPX Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 15, 2026 | $0.04 | -96.24% | $3.31 | -68.85% | -27.39% |
| Sep 14, 2026 | $0.05 | -96.21% | $3.45 | -67.53% | -28.68% |
| Sep 11, 2026 | $0.05 | -95.71% | $3.35 | -68.47% | -27.24% |
| Sep 10, 2026 | $0.05 | -95.80% | $3.35 | -68.47% | -27.33% |
| Sep 09, 2026 | $0.05 | -96.05% | $3.43 | -67.72% | -28.33% |
| Sep 08, 2026 | $0.04 | -96.39% | $3.54 | -66.69% | -29.70% |
| Sep 04, 2026 | $0.07 | -93.79% | $3.50 | -67.06% | -26.73% |
| Sep 03, 2026 | $0.12 | -90.08% | $3.43 | -67.77% | -22.31% |
| Sep 02, 2026 | $0.11 | -91.01% | $3.51 | -66.97% | -24.04% |
| Sep 01, 2026 | $0.14 | -88.49% | $3.55 | -66.59% | -21.90% |
| Aug 31, 2026 | $0.16 | -86.30% | $3.71 | -65.09% | -21.21% |
| Aug 28, 2026 | $0.18 | -84.79% | $3.67 | -65.46% | -19.33% |
| Aug 27, 2026 | $0.72 | -39.58% | $3.61 | -66.03% | +26.45% |
| Aug 26, 2026 | $0.78 | -34.45% | $3.97 | -62.64% | +28.19% |
| Aug 25, 2026 | $0.74 | -37.65% | $4.00 | -62.36% | +24.71% |
Page 1 of 5